February 2007- Volume 3, Issue 2

February 2007

In this Issue

Informatics

More exacting extracting

More exacting extracting

Reel Two, ACD/Labs collaborate on chemical name-to-structure project

Decision to integrate

Decision to integrate

GeneGo\'s MetaCore, MetaDrug integrted with Spotfire\'s DecisionSite

Image is everything

Image is everything

BioImagene to bundle imaging products with HP servers for better customer efficiency

Automation & Instrumentation

Trading their array of technology

Trading their array of technology

Oxford Gne Technology and NimbleGen Systems secure cross-licensing deal

Site on scene lab management

Site on scene lab management

SiteMAX program puts Beckman Coulter in role of managing customers\' equipment.

By-the-slice MS imaging

By-the-slice MS imaging

Protein Discovery rolls out MALDI mass spec imaging by-the-slice service

Genomics & Proteomics

Forget me not

Forget me not

Ablynx and Boehringer Ingelheim sign deal to discover new Alzheimer\'s treatments

A new pitch to stop ALS

A new pitch to stop ALS

ALS Therapy Development Institute (ALS TDI) funds new $36 million, three-year study

New tool for nucleosome charting

New tool for nucleosome charting

Dana-Farber researchers recently developed a new method of charting nucleosomes throughout the human genome.

Canadian scientists release first draft of human metabolome

Canadian scientists release first draft of human metabolome

University of Alberta Researchers cap the three-year $7.5 million Human Metabolome Project

Research & Development

A natural fit

A natural fit

Bristol-Meyers Squibb turns to Albany Molecular Research for natural product collaboration

Raising the yellow flag

Raising the yellow flag

FDA issues precautions to pharma companies over testing at two MDS labs

8-million compound library

8-million compound library

Wyeth taps Pharmacopeia data for immunology and inflammation work

Ardea Biosciences: Drug discovery from the ashes of IntraBiotics

Ardea Biosciences: Drug discovery from the ashes of IntraBiotics

The company formerly known as IntraBiotics Pharmaceuticals, Inc., is rebuilding itself as Ardea Biosciences, Inc., after acquiring intellectual property, data, inventory, and equipment from Valeant Pharmaceuticals International and hiring a new management team.
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

DDN June 2022 magazine issue front cover

Latest Issue  

• Volume 18 • Issue 6 • June 2022

June 2022

June 2022 Issue